NEU Share Price

Open 0.06 Change Price %
High 0.07 1 Day 0.01 16.67
Low 0.06 1 Week 0.01 16.67
Close 0.07 1 Month 0.01 16.67
Volume 2076364 1 Year 0.01 16.67
52 Week High 0.09
52 Week Low 0.04
NEU Important Levels
Resistance 2 0.08
Resistance 1 0.08
Pivot 0.07
Support 1 0.06
Support 2 0.06
ASX Australia Most Active Stocks
EHL 0.09 12.50%
EHL 0.09 12.50%
AGO 0.01 0.00%
AGO 0.01 0.00%
AGO 0.01 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
HHM 0.02 100.00%
SMD 0.02 100.00%
SMD 0.02 100.00%
ANO 0.03 50.00%
ANO 0.03 50.00%
ANO 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
NGY 0.02 -50.00%
GDY 0.01 -50.00%
More..

Neuren Pharmaceuticals Ltd (ASX: NEU)

NEU Technical Analysis 3
As on 23rd Jun 2017 NEU Share Price closed @ 0.07 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.06 & Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
NEU Target for June
1st Target up-side 0.07
2nd Target up-side 0.07
3rd Target up-side 0.07
1st Target down-side 0.05
2nd Target down-side 0.05
3rd Target down-side 0.05
NEU Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.neurenpharma.com
NEU Address
NEU
697 Burke Road
Suite 201
Camberwell, VIC 3124
Australia
Phone: 61 3 9092 0480
NEU Latest News
Unusual Activity Spotted in Neuren Pharmaceuticals Ltd (NEU.AX)   BVN   - 22nd Jun 17
Needle Action Activity Spotted in Neuren Pharmaceuticals Ltd (NEU.AX)   The Herald   - 15th Jun 17
Shares at a Glance: Technical Update on Neuren Pharmaceuticals Ltd (NEU.AX)   Benton Bulletin   - 05th Jun 17
Neuren's Phase 2 trial of trofinetide demonstrates significant clinical ...   GlobeNewswire (press release)   - 25th Mar 17
Neuren: In trading halt pending clinical trial announcement   Finance News Network   - 20th Mar 17
Why the Neuren Pharmaceuticals Ltd share price has crashed today   Motley Fool Australia   - 26th Apr 16
BRIEF-Neuren Pharmaceuticals requests trading halt   Reuters   - 03rd Dec 15
Neuren's NNZ-2566 Successful in Demonstrating Clinical Benefit in Rett ...   Marketwired (press release)   - 12th Nov 14
0.055   MarketWatch   - 16th Aug 13
Neuren Pharmaceuticals' 53% share price jump prompts ASX query   Proactive Investors Australia   - 25th Oct 12
Interactive Technical Analysis Chart Neuren Pharmaceuticals Ltd ( NEU ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Neuren Pharmaceuticals Ltd
NEU Business Profile
Neuren Pharmaceuticals Limited, a biopharmaceutical company, focuses on the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders primarily in the United States. Its product development pipeline includes NNZ-2566 that is in Phase II clinical trials in rett syndrome, fragile X syndrome, and moderate to severe traumatic brain injury, as well as in concussion; and NNZ-2591, which is in preclinical development for chronic neurodegenerative conditions. The company has collaborative relationship with the US Army Medical Research & Materiel Command; and the Walter Reed Army Institute of Research. Neuren Pharmaceuticals Limited is based in Camberwell, Australia.